Distinctive pathologic findings in proximal diabetic neuropathy (diabetic amyotrophy)
Oral Supplements Oral supplements: Do not require medical staff Can be sold online or in person Fall under DSHEA Carry lower legal risk when labeled and marketed correctly Injectable Products Injectable products: Are drugs under the FDCA Require licensed medical oversight Must come from approved or lawfully compounded sources Carry medical and regulatory risk A center that offers injectable NAD+ or glutathione without meeting these requirements exposes itself to FDA and state enforcement
The most frequent symptoms include fever, dyspnea, sore throat, anosmia, dysgeusia, fatigue, and can progress to pneumonia, acute respiratory distress syndrome, and multiorgan dysfunction
Excessive production of transforming growth factor beta1 causes mural cell depletion from cerebral small vessels
Direct-to-consumer marketing and celebrity endorsements have amplified demand, while telehealth expansion made acquisition easier than traditional pharmacy access
